EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates

Lei Yin, Aiyun Xu, Yumeng Zhao, Jingkai Gu

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.123.001313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Lei Yin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Drug Metabolism, School of Life Sciences, Jilin University, Changchun, 130012, PR China (L.Y., A.X., Y.Z., J.G.) and School of Li…. Hauptthemen laut MEDLINE: Immunoconjugates, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesAntineoplastic AgentsTissue DistributionAntibodies, MonoclonalCytotoxins

Substanzen

ImmunoconjugatesAntibodies, MonoclonalAntineoplastic AgentsCytotoxins

Autor:innen und Institutionen

  • Research Center for Drug Metabolism, School of Life Sciences, Jilin University, Changchun, 130012, PR China (L.Y., A.X., Y.Z., J.G.) and School of Life and Pharmaceutical Sciences, Dalian University of Technology, Panji…

Zitieren

APA

Yin, L., Xu, A., Zhao, Y., & Gu, J. (2023). Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001313

Vancouver

Yin L, Xu A, Zhao Y, Gu J. Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001313

BibTeX
@article{Yin2023,
  author = {Yin, Lei and Xu, Aiyun and Zhao, Yumeng and Gu, Jingkai},
  title = {Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.123.001313}
}
Kostenlos starten →